Back
Insmed Vs. MoonLake Immunotherapeutics Industry Stock Comparison
Buy
58
INSM
Insmed
Last Price:
73.25
Seasonality Move:
0.64%
Buy
77
MLTX
MoonLake Immunotherapeutics
Last Price:
51.00
Seasonality Move:
10.4%
Buy
58
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $73.23. The Score for INSM is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
- The current MoonLake Immunotherapeutics [MLTX] share price is $49.98. The Score for MLTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- MLTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INSM Stock Price Chart
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $49.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing selling pressure, which indicates risk of future bearish movement.
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 47.99 | Sell |
| Chaikin Money Flow: | -692401 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.93 - 77.17) | Sell |
| Bollinger Bands (100): | (39.87 - 79.77) | Buy |
MLTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.94 | Buy |
| Relative Strength Index (14 RSI): | 60.12 | Buy |
| Chaikin Money Flow: | -227803 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.08 - 49.38) | Buy |
| Bollinger Bands (100): | (40.67 - 46.95) | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.74 | Buy |
| 20-day SMA: | 75.03 | Sell |
| 50-day SMA: | 74.59 | Sell |
| 200-day SMA: | 43.84 | Buy |
| 8-day EMA: | 73.51 | Sell |
| 20-day EMA: | 74.05 | Sell |
| 50-day EMA: | 71.26 | Buy |
| 200-day EMA: | 50.16 | Buy |
MLTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.94 | Buy |
| 20-day SMA: | 47.97 | Buy |
| 50-day SMA: | 46.19 | Buy |
| 200-day SMA: | 48.37 | Buy |
| 8-day EMA: | 48.74 | Buy |
| 20-day EMA: | 47.69 | Buy |
| 50-day EMA: | 46.26 | Buy |
| 200-day EMA: | 45.63 | Buy |
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.10 per share, and an increase next year of $1.11 per share.
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.79 per share.
Insmed Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MoonLake Immunotherapeutics Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||